Catalyst Nurolight

催化剂 Nurolight

• 批准号: ES/X006425/1
• 负责人: Lesley Palmer
• 金额: $ 6.39万
• 依托单位: University of Stirling
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=ES%2FX006425%2F1
• 关键词: Catalyst; Nurolight

In the UK 45% of people with Alzheimer's experience sleep disturbances which negatively impact their quality of life. Poor sleep can compound symptoms such as memory loss, cognitive decline, and exacerbate behaviours such as agitation and aggression. Sleep disturbance can also negatively impact their care partners resulting in increased stress, depression, and burnout. When the sleep of both people with Alzheimer's and partners is affected, remaining at home becomes more challenging and sleep disruption has been attributed as a significant contributing factor to people with Alzheimer's being admitted into care earlier than necessary. Research demonstrates that light therapy can improve sleep and reduce sleep disruption in mild Alzheimer's. Light therapy research undertaken in the home environment has also demonstrated benefits to care partners such as improved sleep duration and sleep/wake cycle. We propose a new technology ('NuroLight') which offers light therapy, using off-the-shelf products, evidence-based research and smart technology. This aims to improve the quality of life for both the person with Alzheimer's and their partner, reduce care partner burnout, and subsequently reduce early admittance to care for the person with Alzheimer's. With more people with Alzheimer's living in the community and public spending under pressure, supporting people to live well at home is a priority.

在英国，45% 的阿尔茨海默病患者存在睡眠障碍，这对他们的生活质量产生了负面影响。睡眠不佳会加剧记忆力减退、认知能力下降等症状，并加剧烦躁和攻击性等行为。睡眠障碍也会对他们的护理伙伴产生负面影响，导致压力、抑郁和倦怠增加。当阿尔茨海默氏症患者及其伴侣的睡眠都受到影响时，待在家里就变得更具挑战性，而睡眠中断被认为是导致阿尔茨海默氏症患者过早入院的一个重要因素。研究表明，光疗法可以改善轻度阿尔茨海默病的睡眠并减少睡眠中断。在家庭环境中进行的光疗研究也证明了对护理伙伴的好处，例如改善睡眠持续时间和睡眠/觉醒周期。我们提出了一种新技术（“NuroLight”），它利用现成的产品、循证研究和智能技术提供光疗。其目的是改善阿尔茨海默病患者及其伴侣的生活质量，减少护理伴侣的倦怠，并随后减少早期接受护理阿尔茨海默病患者的情况。随着越来越多的阿尔茨海默病患者生活在社区，公共支出面临压力，支持人们在家过上好日子是当务之急。